Pro-Inflammatory Role of MicroRNA-200 in Vascular Smooth Muscle Cells From Diabetic Mice

被引:155
作者
Reddy, Marpadga A. [1 ]
Jin, Wen [1 ]
Villeneuve, Louisa [1 ]
Wang, Mei [1 ]
Lanting, Linda [1 ]
Todorov, Ivan [1 ]
Kato, Mitsuo [1 ]
Natarajan, Rama [1 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet, Duarte, CA 91010 USA
关键词
diabetes mellitus; Zeb1; inflammatory genes; miR-200; vascular complications; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCATION END-PRODUCTS; DB/DB MICE; TRANSCRIPTION FACTORS; FEEDBACK LOOP; COMPLICATIONS; GENE; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION;
D O I
10.1161/ATVBAHA.111.241109
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective-Vascular smooth muscle cells (VSMC) from type 2 diabetic db/db mice exhibit enhanced proinflammatory responses implicated in accelerated vascular complications. We examined the role of microRNA(miR)-200 family members and their target Zeb1, an E-box binding transcriptional repressor, in these events. Methods and Results-The expression levels of miR-200b, miR-200c, and miR-429 were increased, although protein levels of Zeb1 were decreased in VSMC and aortas from db/db mice relative to control db/+ mice. Transfection of miR-200 mimics into VSMC downregulated Zeb1 by targeting its 3'-UTR, upregulated the inflammatory genes cyclooxygenase-2 and monocyte chemoattractant protein-1, and promoted monocyte binding in db/+ VSMC. In contrast, miR-200 inhibitors reversed the enhanced monocyte binding of db/dbVSMC. Zeb1 gene silencing with siRNAs also increased these proinflammatory responses in db/+ VSMC confirming negative regulatory role of Zeb1. Both miR-200 mimics and Zeb1 siRNAs increased cyclooxygenase-2 promoter transcriptional activity. Chromatin immuno-precipitation showed that Zeb1 occupancy at inflammatory gene promoters was reduced in VSMC from type 2 diabetic db/db mice. Furthermore, Zeb1 knockdown increased miR-200 levels demonstrating a feedback regulatory loop. Conclusion-Disruption of the reciprocal negative regulatory loop between miR-200 and Zeb1 under diabetic conditions enhances proinflammatory responses of VSMC implicated in vascular complications. (Arterioscler Thromb Vasc Biol. 2012; 32:721-729.)
引用
收藏
页码:721 / U446
页数:18
相关论文
共 39 条
[1]
Type 2 diabetic mice have increased arteriolar tone and blood pressure - Enhanced release of COX-2-derived constrictor prostaglandins [J].
Bagi, Z ;
Erdei, N ;
Toth, A ;
Li, W ;
Hintze, TH ;
Koller, A ;
Kaley, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1610-1616
[2]
MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]
The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? [J].
Brabletz, Simone ;
Brabletz, Thomas .
EMBO REPORTS, 2010, 11 (09) :670-677
[4]
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition [J].
Bracken, Cameron P. ;
Gregory, Philip A. ;
Kolesnikoff, Natasha ;
Bert, Andrew G. ;
Wang, Jun ;
Shannon, M. Frances ;
Goodall, Gregory J. .
CANCER RESEARCH, 2008, 68 (19) :7846-7854
[5]
Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[6]
Carew RM, 2011, CELL TISSUE RES 0816
[7]
miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells [J].
Chan, Yuk Cheung ;
Khanna, Savita ;
Roy, Sashwati ;
Sen, Chandan K. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (03) :2047-2056
[8]
Devaraj Sridevi, 2010, Expert Rev Endocrinol Metab, V5, P19
[9]
Role of smooth muscle cells in the initiation and early progression of atherosclerosis [J].
Doran, Amanda C. ;
Meller, Nahum ;
McNamara, Coleen A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) :812-819
[10]
Microplate-based chromatin immunoprecipitation method, Matrix ChIP: a platform to study signaling of complex genomic events [J].
Flanagin, Steve ;
Nelson, Joel D. ;
Castner, David G. ;
Denisenko, Oleg ;
Bomsztyk, Karol .
NUCLEIC ACIDS RESEARCH, 2008, 36 (03)